This association may coincide with estrogenic response on gene expression and highlight the effect of TAM usage in hyperthyroid patients, especially considering the proliferative and apoptotic effects of TGFA and TGFB1, respectively, on the initial tumor progression stages. The gene discussed is TGFB1; the disease is neoplasm.